Is Mako the next big thing in Africa?

|

Published 05-SEP-2019 11:33 A.M.

|

3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

At today’s Africa Down Under Conference being held in Perth, Mako Gold Ltd (ASX:MKG) managing director Peter Ledwidge will be outlining the company’s strategy in progressing its gold projects in Côte d’Ivoire and Burkina Faso.

He will have plenty to discuss given that the company is rapidly advancing the Napié Project in Côte d’Ivoire and is looking to build on a gold discovery at the Niou Project in Burkina Faso.

Significant widths and high-grade gold have been intersected at both projects, and Ledwidge is of the view that they both have the potential to be multi-million ounce gold deposits which are characteristic of the regions where they are located.

Importantly, both Peter and Ann Ledwidge who is general manager exploration have extensive experience in exploring and developing gold projects in Africa with the latter leading the team which discovered the 2 million ounce Natougou deposit for Orbis Gold.

Peter was also involved in that development, and both are geologists with combined experience of 55 years.

Plenty of activity in Côte d’Ivoire

The final results of the recent exploration program being undertaken at the Napié Project in Côte d’Ivoire came just days after Mako lodged two applications for exploration permits with the Ministry of Mines in Côte d’Ivoire that would more than double the company’s footprint in the region to 520 square kilometres.

These applications cover 17 kilometres of highly prospective Greenstone-Granite contact, and they lie within 30 kilometres of Barrick Gold’s 4.9 million ounce Tongon Mine.

Consequently, if Mako is successful with its application, this could well be a market moving development.

Reflecting on the company’s drilling results, they have been outstanding thus far with the Napié Project potentially comparable with the $31 billion capped Barrick Gold’s 4.9 million ounce Tongon project lying to the north-east and the $1 billion capped Perseus Mining’s (ASX:PRU) 3.4 million ounce Yaoure project situated to the south.

Mako is earning up to a 75% interest in the Napié Project under a farm-in and joint venture agreement with Occidental Gold SARL, a subsidiary of Perseus. Mako currently holds a 51% interest in the permit and is the operator of the project.

The majority of the results released in August were received from the remaining eight holes of the Tchaga Prospect.

Select results from the July campaign can be seen below.

Wide zones at Niou bode well for the future

The Niou Project in Burkina Faso delivered outstanding results at the start of the year with wide, high-grade gold returned in the maiden drilling campaign.

The following graphic shows the quality of the results, as well as underlining the geological trends which could well come into play when the next round of drilling commences (see planned drilling in red).

Consequently, there are multiple share price catalysts in the pipeline and no doubt Ledwidge will be underlining these when he presents today at the well-regarded Africa Down Under Conference, now in its sixteenth year.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X